Skip to content

Bohai Pharmaceuticals Group, Inc.

CIK 0001443242

← back to feed
Revenue (TTM)
$180.14M
+15.3% YoY Q1 Sep 2014
Net Income (TTM)
$27.37M
+14.5% YoY Q1 Sep 2014
EPS Diluted (TTM)
$1.32
+12.1% YoY Q1 Sep 2014
Gross Margin
76.4%
Q1 Sep 2014
Operating Margin
21.6%
Q1 Sep 2014
Net Margin
15.2%
Q1 Sep 2014
Free Cash Flow (TTM)
$17.11M
Q1 Sep 2014
Cash
$27.14M
Q1 Sep 2014
Total Debt
$4.87M
Q1 Sep 2014
Shares Outstanding
19.25M sh
Q1 Sep 2014

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings